These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 23054618

  • 21. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
    Lin Fde M, Pincerato KM, Bacchi CE, Baracat EC, Carvalho FM.
    J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
    [Abstract] [Full Text] [Related]

  • 22. Thymic epithelial neoplasms with sebaceous differentiation: a clinicopathological and immunohistochemical study of 8 cases.
    Kalhor N, Moran CA.
    Hum Pathol; 2019 Apr; 86():124-128. PubMed ID: 30537491
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Thymoma and thymic carcinoma in children and adolescents: a report from the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT).
    Stachowicz-Stencel T, Orbach D, Brecht I, Schneider D, Bien E, Synakiewicz A, Rod J, Ferrari A, Cecchetto G, Bisogno G.
    Eur J Cancer; 2015 Nov; 51(16):2444-52. PubMed ID: 26259494
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type b3 thymoma or lung squamous cell carcinoma.
    Hayashi A, Fumon T, Miki Y, Sato H, Yoshino T, Takahashi K.
    J Clin Exp Hematop; 2013 Nov; 53(1):9-19. PubMed ID: 23801129
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Staging of thymic epithelial neoplasms: thymoma and thymic carcinoma.
    Weissferdt A, Moran CA.
    Pathol Res Pract; 2015 Jan; 211(1):2-11. PubMed ID: 25441660
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers.
    Micello D, Marando A, Sahnane N, Riva C, Capella C, Sessa F.
    Virchows Arch; 2010 Oct; 457(4):467-76. PubMed ID: 20809337
    [Abstract] [Full Text] [Related]

  • 36. [Thymic epithelial neoplasms: updates on diagnosis, staging, biology and management in France].
    Hadoux J, Girard N, Besse B.
    Bull Cancer; 2012 Nov; 99(11):1045-55. PubMed ID: 23131309
    [Abstract] [Full Text] [Related]

  • 37. Thymic stroma and TFII-I: towards new targeted therapies.
    Manti PG, Trattaro S, Castaldi D, Pezzali M, Spaggiari L, Testa G.
    Trends Mol Med; 2022 Jan; 28(1):67-78. PubMed ID: 34865984
    [Abstract] [Full Text] [Related]

  • 38. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.
    Hishima T, Fukayama M, Hayashi Y, Fujii T, Arai K, Shiozawa Y, Funata N, Koike M.
    Hum Pathol; 1998 Apr; 29(4):330-8. PubMed ID: 9563781
    [Abstract] [Full Text] [Related]

  • 39. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y.
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.